
# Title 21— FOOD AND DRUGS
### CHAPTER 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT
#### § 331. Prohibited acts
###### (tt) Making any express or implied statement or representation directed to consumers with respect to a tobacco product, in a label or labeling or through the media or advertising, that either conveys, or misleads or would mislead consumers into believing, that

(1) the product is approved by the Food and Drug Administration;

(2) the Food and Drug Administration deems the product to be safe for use by consumers;

(3) the product is endorsed by the Food and Drug Administration for use by consumers; or

(4) the product is safe or less harmful by virtue of

(A) its regulation or inspection by the Food and Drug Administration; or

(B) its compliance with regulatory requirements set by the Food and Drug Administration; including any such statement or representation rendering the product misbranded under section 387c of this title .

(uu) The operation of a facility that manufactures, processes, packs, or holds food for sale in the United States if the owner, operator, or agent in charge of such facility is not in compliance with section 350g of this title .

(vv) The failure to comply with the requirements under section 350h of this title .

(ww) The failure to comply with section 350i of this title .

(xx) The refusal or failure to follow an order under section 350 l of this title.

(yy) The knowing and willful failure to comply with the notification requirement under section 350f(h) of this title .

(zz) The importation or offering for importation of a food if the importer (as defined in section 384a of this title ) does not have in place a foreign supplier verification program in compliance with such section 384a of this title .

(aaa) The failure to register in accordance with section 381(s) of this title .

(bbb) The failure to notify the Secretary in violation of section 360bbb–7 of this title .

(ccc)

(1) The resale of a compounded drug that is labeled “not for resale” in accordance with section 353b of this title .

(2) With respect to a drug to be compounded pursuant to section 353a or 353b of this title, the intentional falsification of a prescription, as applicable.

(3) The failure to report drugs or adverse events by an entity that is registered in accordance with subsection (b) of section 353b of this title .

(ddd)

(1) The manufacture or the introduction or delivery for introduction into interstate commerce of a rinse-off cosmetic that contains intentionally-added plastic microbeads.

(2) In this paragraph

(A) the term “plastic microbead” means any solid plastic particle that is less than five millimeters in size and is intended to be used to exfoliate or cleanse the human body or any part thereof; and

(B) the term “rinse-off cosmetic” includes toothpaste.

(eee) The failure to comply with any order issued under section 360bbb–8d of this title .
